A $6.2 Billion Hedge Fund Dumps These 2 Stocks

Bobby Sankhagowit • 5 minute read
Reviewed by: Bobby Sankhagowit
Last updated Nov 17, 2026

@Santri Bisa Desain from Bu Rezkia via Canva, @Thx4Stock via Canva

Key Takeaways

  • ValueAct Capital’s latest 13F shows it sold all of its Roblox and CBRE shares in the third quarter.
  • Roblox has guided fourth-quarter bookings down 10% to 15%, and analysts’ average target is down about two-thirds in a year.
  • CBRE grew core EPS 28% last quarter, and analysts’ average target sits 28% above the stock.
  • The fund also opened new positions in Agilent and Medline, and the numbers back its Roblox exit far more than its CBRE exit.

ValueAct Capital sold every share it owned of two well-known stocks in the third quarter: Roblox (RBLX) and CBRE Group (CBRE). That’s according to its 13F for the quarter ended Sept. 30, filed Nov. 16, which shows $6.18 billion of US stocks across 21 positions. In the same quarter, it opened new positions in Agilent Technologies (A) and Medline (MDLN).

Roblox’s outlook kept slipping

At June 30, ValueAct held 3.15 million Roblox shares worth $171 million, 3.0% of the fund. By Sept. 30, it held none, and the stock is down 15% since then.

The news out of Roblox since has been rough. On Oct. 29, it guided fourth-quarter bookings down 10% to 15% and free cash flow to -$190 million to -$105 million, as it spends more on AI infrastructure and on marketing aimed at adults. Then on Nov. 13, Citi downgraded the stock to Neutral from Buy. It pointed to fading interest in Roblox’s hit game Steal an Egg and to Grand Theft Auto VI’s Nov. 19 launch pulling playtime away.

Analysts have cut their targets hard over the year. The average now sits at $50.30, down from $146.02 a year ago:

Line chart from TIKR of Roblox's analysts' consensus (mean) price target, $ per share, last year.
Roblox (RBLX): analysts’ consensus (mean) price target, $ per share, last year (TIKR)

That’s just 9% above the last close.

TIKR tracks 22 analysts on Agilent Technologies. How many say “Buy”?

See the full breakdown of Buy, Hold, and Sell ratings on Agilent Technologies, along with Wall Street’s revenue and earnings estimates, all in one place. More than 500,000 investors use TIKR to research stocks like this one. See Agilent Technologies’ Analyst Ratings

CBRE’s earnings are still climbing

ValueAct’s CBRE stake was smaller: 992,391 shares worth $134 million at June 30, 2.4% of the fund, and none by Sept. 30. The stock is down 1% since.

The business has kept growing. On Oct. 22, CBRE reported third-quarter core EPS up 28% to $2.05 on revenue up 13% to $11.5 billion, with infrastructure services revenue up 50% to $4.5 billion over the trailing 12 months. It also stood by its 2026 core EPS guidance of $7.80 to $7.90, about 23% growth at the midpoint. On the call, management said it sees a path to about 15% core EPS growth in 2027.

Analysts have barely budged. Their average target is $170.25, a touch below $175.27 a year ago:

Line chart from TIKR of CBRE Group's analysts' consensus (mean) price target, $ per share, last year.
CBRE Group (CBRE): analysts’ consensus (mean) price target, $ per share, last year (TIKR)

Even the lowest target, $141, sits above the stock’s $133.17.

ValueAct added two health care names

ValueAct also opened two new positions in the quarter: 1.06 million Agilent shares worth $182 million (2.9% of the fund, its No. 11 holding) and 4.15 million Medline shares worth $144 million (2.3%, its No. 12). Medline is up 13% since Sept. 30, including an 18% jump on Nov. 4 after a third-quarter beat, a raised sales outlook and a $1 billion buyback. Agilent is up 0.4% and sits 6% below its 52-week high. Its average target of $183.14 is just 6% above the stock, with its next report due later this month. Both trade at about 26x forward earnings, and Medline’s $45.32 average target leaves 16% of upside.

The numbers back the Roblox sale

Roblox is cheap against its own history: it trades at about 4.9x forward sales, below its five-year average of about 7.8x. But the estimates behind that multiple are still falling. Analysts’ 2027 bookings estimate stands at $7.85 billion, down from $10.2 billion on March 31. Roblox’s best counterpoint is its older players: users 18 and older made up 37% of its US age-checked daily users in the third quarter, up from 33% in the second. Still, I wouldn’t want to own a stock whose estimates keep shrinking and whose average target sits barely above the price.

CBRE is much harder to argue against. At about 16x forward earnings, the stock is cheap for a company guiding to 23% core EPS growth this year, and analysts see 28% upside to their average target. The risk sits in its property deals business: management expects real estate capital markets to stay roughly flat, so more of the growth has to come from its data center and infrastructure work.

If I had to undo one of these sales, it’d be CBRE. Roblox’s next report, likely in early February, will show how much Grand Theft Auto VI cut into its holiday quarter. ValueAct’s next 13F, due by mid-February, will show whether the fund went back into either stock.

So what is Roblox stock actually worth?

TIKR lets you forecast the future price of any stock in less than a minute. Just enter a few assumptions into TIKR’s valuation model and see what Roblox could be worth. Start from Wall Street consensus estimates, or adjust the inputs to reflect your own view of the business. It’s free to use.

Value Roblox for free

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any of the stocks mentioned. Thank you for reading, and happy investing!

Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.

Sign Up for FREENo credit card required